Search results
Checking in on Regeneron Pharmaceuticals, Inc.
Knox Daily· 19 hours agoRegeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr 01 ...
Truist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoTruist Financial Corp reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.4% in the fourth quarter, according ...
RWA Wealth Partners LLC Invests $375,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 6 days agoRWA Wealth Partners LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company ...
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends - Regeneron Pharmaceuticals...
Benzinga· 2 days agoLoading... Loading... Benzinga's options scanner has just identified more than 16 option transactions on Regeneron Pharmaceuticals REGN , with a cumulative ...
Regeneron Pharmaceuticals, Inc. [NASDAQ: REGN] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regeneron Pharmaceuticals, ...
Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences
Market Watch· 7 days agoBy Colin Kellaher Regeneron Pharmaceuticals has inked a deal with privately held Mammoth Biosciences to research, develop and commercialize Crispr-based...
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 7 days agoStocks recently featured in the blog include: Danaher Corp. DHR,Regeneron Pharmaceuticals, Inc....
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
WSAU Wausau· 7 days ago(Reuters) - Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop...
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 7 days agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Mammoth Biosciences to Receive $100M Upfront in Therapeutic CRISPR Gene Editing Deal With Regeneron
GenomeWeb News· 7 days agoRegeneron Pharmaceuticals said Thursday that it will collaborate with Mammoth Biosciences on the research, development, and commercialization of therapies ...
